CANCER RISK ASSOCIATED WITH LOW DOSE AND LOW DOSE-RATE IONIZING RADIATION EXPOSURE

来源 :第三届亚洲辐射研究大会 | 被引量 : 0次 | 上传用户：nj_lcj

【摘要】

：

【作者】

：

Suminori Akiba

【机构】

：

Department of Epidemiology and Preventive Medicine,Kagoshima University Graduate,School of Medical a

【出处】

：

第三届亚洲辐射研究大会

【发表日期】

：

2013年2期

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

This paper discusses the effect of dose rate on the magnitude of relationship between radiation exposure and cancer risk, by reviewing the important epidemiological studies that examined the cancer risk associated with external exposure to low-LET ionizing radiation (such as X-rays and gamma rays).

其他文献

CHEMORADIOTHERAPY FOR ESOPHAGEAL CANCER

Esophageal cancer is still one of the deadliest cancers today with the average 5-years survival rate less than 25％.Although the diagnosis and the treatment options have been improved during the past d

会议

CURRENT STATUS OF CHEMORADIOTHERAPY FOR CERVICAL CANCER IN JAPAN

Based on the results of several randomized phase Ⅲ clinical studies and meta-analyses, concurrent chemoradiotherapy (CCRT) using weekly cisplatin or the combination of cisplatin and 5-FU has become th

会议

Cervical cancerChemoradiotherapyHigh dose-rate brachytherapy3D image-guided b

CHEMORADIOTHERAPY FOR PANCREATIC CANCER

Pancreatic cancer is one of the leading causes of cancer death worldwide.The prognosis of patients with this disease remains extremely poor, with a 5-year survival rate after diagnosis of less than 5％

会议

Radiotherapychemotherapypancreatic cancer

HSP27 AS A MOLECULAR TARGET FOR RADIATION THERAPY

Heat shock protein 27 (HSP27), which is highly expressed in various cancer tissues,induced resistance to cell death against various stimuli.

会议

CLINICAL AND MOLECULAR BASIS FOR COMBINED MOLECULAR TARGETING DRUGS WITH RADIATION THERAPY

Molecular target-based drugs have been emerging as a cancer treatment, and clinical trials using combined approach of radiation therapy and molecular target-based drugs have been performed to evaluate

会议

radiation therapymolecular targeting drugssurrogate markertoxicityradiosensi

MOUSE URINARY HEPCIDIN-2 IS A POTENTIAL BIOMARKER OF RADIATION EXPOSURE

To identify urinary biomarker of radiation exposure, we separated urine obtained from whole body gamma-irradiated mouse at 4 Gy using high performance liquid chromatography, and then analyzed each fra

会议

Urinary hepcidin-2Radiation exposurebiomarker

IMMUNOLOGICAL CHANGES OF CHRONIC ORAL EXPOSURE TO DEPLETED URANIUM IN MICE

Direct ingestion of contaminated soil by depleted uranium (DU) might lead to internal exposure to DU by local populations through hand contamination.The purpose of this study was to assess the immunol

会议

depleted uraniumintakeimmune functioncytokine

THE HISTONE VARIANT MACROH2A1.1 IS RECRUITED TO DAMAGE SITES UPON DNA DOUBLE-STRAND BREAKS

The repair of DNA double-strand breaks (DSBs) is a complex process involving activation of the ATM kinase and loading of DNA repair proteins onto the chromatin at the site of damage.

会议

DNA double-strand breaks (DSBs)macroH2A1ionizing radiationzinc finger nucleas

FOLLOW-UP STUDY OF ABNORMAL BIOLOGICAL INDICATORS AND GENE EXPRESSION IN THE PERIPHERAL BLOOD OF THR

Purpose: In order to identify biomarkers for early diagnosis and/or for therapeutic targets in the late health effects of ionizing radiation, we analyzed the frequencies of chromosome aberrations, cyt

会议

Accidental exposureGene expression profileRatio of Th to TsRadiation biomarke

DOSE-DEPENDENT AUGMENTATION OF γ-H2AX IN PERIPHERAL BLOOD LYMPHOCYTES BUT NOT IN GRANULOCYTES: THE R

Purpose: To assess the use of RL/G of γ-H2AX (ratio of γ-H2AX in lymphocytes to that in granulocytes) in blood as a rapid method for population triage and doses estimation in events of large-scale rad

会议

RL/G of γ-H2AXradiationlymphocytesgranulocytesflow cytometry

CANCER RISK ASSOCIATED WITH LOW DOSE AND LOW DOSE-RATE IONIZING RADIATION EXPOSURE

与本文相关的学术论文